A crossover study of risperidone in children, adolescents and adults with mental retardation. 2006

Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
Department of Psychiatry, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, USA. jhelling@kumc.edu

Risperidone has shown safety and efficacy for aggressive and destructive behaviors in short-term studies. This longer-duration study includes a broad sample. Forty subjects, aged 8-56 years (mean=22), all with mental retardation and 36 with autism spectrum disorders participated in this 22-week crossover study, with 24 weeks of open maintenance thereafter. Of 40 subjects, 23 (57.5%) responded fully (50% decrease in Aberrant Behavior Checklist-Community Irritability subscale score), while 35 subjects (87.5%) showed a 25% decrease. Gender, mood disorder, and antiseizure medications did not alter response. Increased appetite and weight gain were common. Low dose risperidone was effective for aggressive behavior in persons with MR. More long-term studies are needed, incorporating weight control interventions.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000374 Aggression Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism. Aggressions

Related Publications

Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
August 2005, Journal of the American Academy of Child and Adolescent Psychiatry,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
June 1998, Journal of autism and developmental disorders,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
June 2005, European journal of clinical pharmacology,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
January 1995, Research in developmental disabilities,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
January 1995, Research in developmental disabilities,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
March 2003, American journal of mental retardation : AJMR,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
January 1996, Psychopharmacology bulletin,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
June 2006, Mental retardation,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
October 2013, Journal of autism and developmental disorders,
Jessica A Hellings, and Jennifer R Zarcone, and R Matthew Reese, and Maria G Valdovinos, and Janet G Marquis, and Kandace K Fleming, and Stephen R Schroeder
September 2006, Journal of child psychology and psychiatry, and allied disciplines,
Copied contents to your clipboard!